title: Reply: Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI Registry.
authors.forename: Katharina
authors.initials: K
authors.lastname: Mayer
authors.forename: Isabell
authors.initials: I
authors.lastname: Bernlochner
authors.forename: Siegmund
authors.initials: S
authors.lastname: Braun
authors.forename: Stefanie
authors.initials: S
authors.lastname: Schulz
authors.forename: Martin
authors.initials: M
authors.lastname: Orban
authors.forename: Tanja
authors.initials: T
authors.lastname: Morath
authors.forename: Lisena
authors.initials: L
authors.lastname: Cala
authors.forename: Petra
authors.initials: P
authors.lastname: Hoppmann
authors.forename: Heribert
authors.initials: H
authors.lastname: Schunkert
authors.forename: Karl-Ludwig
authors.initials: KL
authors.lastname: Laugwitz
authors.forename: Adnan
authors.initials: A
authors.lastname: Kastrati
authors.forename: Dirk
authors.initials: D
authors.lastname: Sibbing
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D013988:Ticlopidine; D001241:Aspirin